![Matthew Kowalsky](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Kowalsky
Conseiller Juridique Général chez
ENANTA PHARMACEUTICALS, INC.
Fortune : 52 357 $ au 30/06/2026
Profil
Matthew P.
Kowalsky is Secretary & Chief Legal Officer at Enanta Pharmaceuticals, Inc. since 2024.
Formerly, Mr. Kowalsky was Secretary & Chief Legal Officer at Sigilon Therapeutics, Inc., Secretary & Vice President-Legal at Proteon Therapeutics, Inc. from 2016 to 2019, Senior Corporate Counsel at Genzyme Corp.
from 2015 to 2016, Associate General Counsel at Cubist Pharmaceuticals LLC from 2013 to 2015, Assistant General Counsel at ARIAD Pharmaceuticals, Inc. in 2013, and Assistant General Counsel at Lantheus Medical Imaging, Inc. from 2009 to 2013.
Education includes undergraduate and graduate degrees from the University of Notre Dame and the University of Notre Dame The Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/02/2026 | 3 591 ( 0,01% ) | 52 357 $ | 30/06/2026 |
Postes actifs de Matthew Kowalsky
| Sociétés | Poste | Début |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Conseiller Juridique Général | 30/04/2024 |
Anciens postes connus de Matthew Kowalsky
| Sociétés | Poste | Fin |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Conseiller Juridique Général | 01/01/2019 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/05/2016 |
| CUBIST PHARMACEUTICALS INC | Conseiller Juridique Général | 01/01/2015 |
| ARIAD PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/11/2013 |
Lantheus Medical Imaging, Inc.
 Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Develops and manufactures radio diagnostics | Conseiller Juridique Général | 01/01/2013 |
Formation de Matthew Kowalsky
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops pharmaceuticals products for patients with renal and vascular disease | Health Technology |
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Develops and manufactures radio diagnostics | Health Technology |
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enanta Pharmaceuticals, Inc.
 Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
University of Notre Dame The Law School
 University of Notre Dame The Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
